Senior Director, Regulatory Affairs

The Senior Director, Regulatory Affairs leads and coordinates regulatory interactions and submission execution for ARTBIO’s clinical-stage radiopharmaceutical programs. This role is primarily responsible for coordinating regulatory medical writing across functions. The position works cross-functionally to translate research and development data and strategy into clear, compliant regulatory communications and high-quality submission deliverables.

• Serves as the point of contact for Health Authorities.
• Translates program regulatory strategy into clear interaction plans, submission plans, timelines, and cross-functional deliverables for ARTBIO’s clinical-stage radiopharmaceutical programs.
• Leads the preparation, coordination, and delivery of regulatory submissions, including INDs, IND amendments, annual reports, meeting requests, CTAs, and other lifecycle submissions.
• Schedules and coordinates meeting rehearsals prior to Health Authority interactions.
• Finalizes meeting minutes with Health Authorities, responses to information requests, and follow-up actions.
• Oversees publishing and submissions.
• Partners with Clinical, Medical, CMC, Quality, Nonclinical, Clinical Operations, and other contributors to develop content, resolve data gaps, and maintain an aligned submission narrative.
• Maintains clear records of correspondences, commitments, decisions, and submission history.
• Establishes and maintains regulatory plans, workflows, submission calendars, trackers, and archives.

• Bachelor’s degree in a scientific, medical, pharmacy, or related discipline is required; an advanced degree is preferred.
• 12+ years of progressive regulatory affairs experience in the biotech or pharmaceutical industry, including demonstrating leadership in leading the deliverables for regulatory interactions supporting pre-IND to Phase 3 investigational-stage programs in oncology.
• Strong knowledge of US FDA requirements and interaction processes
• Proven track record coordinating US INDs, IND amendments, annual reports, health authority meeting packages, and responses to US FDA information requests.
• Hands-on experience with electronic submission publishing, document management, submission standards, and external publishing vendors.
• Experience and familiarity with leading submission of New Drug Applications, Marketing Authorization Applications, and radiopharmaceutical development are helpful.

• Clear, concise communicator with strong scientific judgment and exceptional writing and editing skills.
• Highly organized, proactive, and detail-oriented, with disciplined follow-through on commitments and timelines.
• Comfortable working in a fast-paced biotech environment with evolving priorities and multiple stakeholders.
• Collaborative leader who can align subject matter experts, challenge constructively, and drive decisions without losing momentum.
• Commitment to quality, compliance, and patient safety.

• A unique chance to contribute to first-in-class cancer therapies.
• Exposure to both radiochemistry and CMC development in a dynamic biotech setting.
• Hands-on training and professional development opportunities.
• An international, collaborative, and supportive work culture.
• Competitive compensation and benefits.

Channeling Energy. Changing Lives. ARTBIO redefines cancer care by discovering and developing a new class of Alpha Radioligand Therapies (ARTs), powered by unique Pb-212 isotope technology and seamless supply. Our team works tirelessly to bring therapies that matter to patients who need them.

The unique ARTBIO approach selects the optimal alpha-precursor isotope (212

Pb) and tumor‑specific targets to create therapeutics with the potential for the highest efficacy…